There are several classification systems for Ebstein anomaly, the most commonly used are the Carpentier classification (anatomical classification) and the Celermajer index or the Great Ormond Street Echocardiography (GOSE) score for neonates.
These classification systems are crucial for determining the severity of the Ebstein anomaly.
Carpentier classification
-
type A: mild
mild apical displacement of the septal and posterior tricuspid valve leaflets
small "atrialised" ventricle
adequate function of the functional right ventricle
-
type B: moderate
moderate apical displacement of the septal and posterior tricuspid valve leaflets
abnormal attachment of the otherwise freely mobile anterior leaflet
moderately sized "atrialised" ventricle with reduced function
reduced volume but adequate function of the functional right ventricle
-
type C: severe
severe apical displacement of the septal and posterior tricuspid valve leaflets
abnormal attachments restricting the mobility of the anterior leaflet and potentially obstructing the right ventricular outflow tract
large "atrialised" ventricle with reduced function
small functional right ventricle
-
type D: extensive (tricuspid valve sac)
complete non-delamination of the tricuspid valve leaflets
multiple abnormal attachments
almost complete "atrialisation" of the right ventricle with the exception of a small insufficient infundibular component
Great Ormond Street Echocardiography (GOSE) score
The GOSE score uses the ratio of the combined area of the right atrium (RA) and atrialised right ventricle (aRV) versus the combined area of the functional right ventricle (fRV), left atrium (LA), and left ventricle (LV):
GOSE score: area (RA+aRV) / area (fRV+LA+LV)
grade 1: < 0.5
grade 2: 0.5-0.99
grade 3: 1-1.49
grade 4: ≥ 1.5
History and etymology
In 1988, the French cardiac surgeon Alain Frédéric Carpentier and colleagues established a classification of Ebstein anomaly based on the anatomy of the right ventricle and the tricuspid valve 3.
The GOSE scoring system was developed by the British cardiologist David Celermajer during research on 50 individuals with neonatal Ebstein anomalies from 1961 to 1990 5.